|
1.
|
|
9 p, 824.5 KB |
High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome
/
Blanco, Gonzalo (Hospital del Mar (Barcelona, Catalunya)) ;
López-Aventín, Daniel (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Pujol Vallverdú, Ramón M (Hospital del Mar (Barcelona, Catalunya)) ;
Gómez-Llonín, Andrea (Hospital del Mar (Barcelona, Catalunya)) ;
Puiggros, Anna (Hospital del Mar (Barcelona, Catalunya)) ;
López-Sánchez, Manuela (Hospital Clínico Universitario Virgen de la Arrixaca) ;
Estrach, Teresa (Hospital Clínic i Provincial de Barcelona) ;
Garcia Muret, Maria Pilar (Institut d'Investigació Biomèdica Sant Pau) ;
Lopez-Lerma, Ingrid (Hospital Universitari Vall d'Hebron) ;
Servitje, Octavio (Hospital Universitari de Bellvitge) ;
Bellosillo Paricio, Beatriz (Hospital del Mar (Barcelona, Catalunya)) ;
Muro, Manuel (Hospital Clínico Universitario Virgen de la Arrixaca (El Palmar, Múrcia)) ;
Espinet, Blanca (Hospital del Mar (Barcelona, Catalunya)) ;
Rabionet, Raquel (Instituto de Salud Carlos III) ;
Gallardo, Fernando (Hospital del Mar (Barcelona, Catalunya))
Previous investigations pointed out a role for antigen stimulation in Sezary syndrome (SS). High-throughput sequencing of the T cell receptor (TR) offers several applications beyond diagnostic purposes, including the study of T cell pathogenesis. [...]
2023 -  10.1002/jcla.24982
Journal of Clinical Laboratory Analysis, Vol. 37 (december 2023)
|
|
|
2.
|
|
|
3.
|
|
16 p, 4.7 MB |
BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases
/
Carbo-Meix, Anna (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Guijarro, Francesca (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Wang, Luojun (Hospital Clínic i Provincial de Barcelona) ;
Grau, Marta (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Royo, Romina (Barcelona Supercomputing Center) ;
Frigola, Gerard (Hospital Clínic i Provincial de Barcelona) ;
Playa-Albinyana, Heribert (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Buhler, Marco M. (University Hospital Zurich (Suïssa)) ;
Clot, Guillem (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Duran-Ferrer, Marti (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Lu, Junyan (European Molecular Biology Laboratory, Heidelberg) ;
Granada, Isabel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Baptista, Maria Joao (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Navarro, Jose Tomas (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Espinet, Blanca (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Puiggros, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Tapia, Gustavo (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bandiera, Laura (Anatomia Istologia Patologica e Citogenetica. Dipartimento Ematologia. Oncologia e Medicina Molecolare. Niguarda Cancer Center, Milano) ;
De Canal, Gabriella (Anatomia Istologia Patologica e Citogenetica. Dipartimento Ematologia. Oncologia e Medicina Molecolare. Niguarda Cancer Center, Milano) ;
Bonoldi, Emanuela (Anatomia Istologia Patologica e Citogenetica. Dipartimento Ematologia. Oncologia e Medicina Molecolare. Niguarda Cancer Center, Milano) ;
Climent, Fina (Institut d'Investigació Biomèdica de Bellvitge) ;
Ribera-Cortada, Inmaculada (Hospital Nostra Senyora de Meritxell. Escaldes-Engordany. Principat d'Andorra) ;
Fernandez-Caballero, Mariana (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
De la Banda, Esmeralda (Institut d'Investigació Biomèdica de Bellvitge) ;
Do Nascimento, Janilson (Hospital Joan XXIII, Institut Català d'Oncologia, Tarragona) ;
Pineda, Alberto (Fundació Hospital de l'Esperit Sant) ;
Vela, Dolors (Hematologia Clínica. Hospital General de Granollers) ;
Rozman, Maria (Hospital Clínic i Provincial de Barcelona) ;
Aymerich, Marta (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Syrykh, Charlotte (Cancer Institute University of Toulouse-Oncopole, France) ;
Brousset, Pierre (Cancer Institute University of Toulouse-Oncopole, France) ;
Perera, Miguel (Hospital Dr Negrín, Las Palmas de Gran Canaria) ;
Yanez, Lucrecia (Hematology Department. Hospital Universitario Marqués de Valdecilla-Instituto de Investigación Valdecilla) ;
Ortin, Jesus Xavier (Hematology Department. Hospital Verge de la Cinta) ;
Tuset, Esperanza (Institut d'Investigació Biomèdica de Girona) ;
Zenz, Thorsten (University Hospital and University of Zürich) ;
Cook, James R. (Pathology and Laboratory Medicine Institute. Cleveland Clinic) ;
Swerdlow, Steven H. (University of Pittsburgh School of Medicine) ;
Martin-Subero, Jose I. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Colomer, Dolors (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Matutes, Estella (Hospital Clínic i Provincial de Barcelona) ;
Bea, Silvia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Costa, Dolors (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Nadeu, Ferran (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Campo, Elias (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
The t(14;19)(q32;q13) often juxtaposes BCL3 with immunoglobulin heavy chain (IGH) resulting in overexpression of the gene. In contrast to other oncogenic translocations, BCL3 rearrangement (BCL3-R) has been associated with a broad spectrum of lymphoid neoplasms. [...]
2024 - 10.3324/haematol.2023.283209
Haematologica, Vol. 109 Núm. 2 (february 2024) , p. 493-508
|
|
|
4.
|
|
11 p, 771.0 KB |
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
/
Cabrera Serrano, Antonio José (Instituto de Investigación Sanitaria de Granada) ;
Sánchez Maldonado, José Manuel (Instituto de Investigación Sanitaria de Granada) ;
ter Horst, Rob (CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences) ;
Macauda, Angelica (German Cancer Research Center) ;
García Martín, Paloma (Hospital Campus de la Salud (Granada)) ;
Benavente, Yolanda (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Landi, Stefano (Department of Biology. University of Pisa) ;
Clay-Gilmour, Alyssa (Department of Epidemiology & Biostatistics. Arnold School of Public Health. University of South Carolina) ;
Niazi, Yasmeen (Hopp Children's Cancer Center) ;
Espinet, Blanca (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Rodriguez-Sevilla, Juan Jose (Department of Leukemia. The University of Texas MD Anderson Cancer Center) ;
Pérez, Eva María (Hospital Campus de la Salud) ;
Maffei, Rossana (University of Modena and Reggio Emilia) ;
Blanco, Gonzalo (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Giaccherini, Matteo (Department of Biology. University of Pisa) ;
Cerhan, James R. (Department of Quantitative Health Sciences. Mayo Clinic) ;
Marasca, Roberto (Department of Medical and Surgical Sciences. University of Modena and Reggio Emilia. AOU Policlinico) ;
Lopez Nevot, Miguel Angel (Hospital Universitario Virgen de las Nieves (Granada)) ;
Chen-Liang, Tzu Hua (Hospital Universitario Morales Meseguer (Múrcia)) ;
Thomsen, Hauke (MSB Medical School Berlin) ;
Gámez, Irene (Hematology Department. Morales Meseguer University Hospital) ;
Campa, Daniele (Department of Biology. University of Pisa) ;
Moreno Aguado, Víctor (Facultat de Medicina. Universitat de Barcelona) ;
de Sanjosé, Silvia (Universitat de Barcelona) ;
Marcos-Gragera, Rafael (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
García-Álvarez, María Flor (Instituto de Investigación Biomédica de Salamanca) ;
Dierssen-Sotos, Trinidad (Universidad de Cantabria) ;
Jerez, Andrés (Vall d'Hebron Institut d'Oncologia) ;
Butrym, Aleksandra (Department of Cancer Prevention and Therapy. Medical University of Wrocław) ;
Norman, Aaron D. (Department of Quantitative Health Sciences. Mayo Clinic) ;
Luppi, Mario (University of Modena and Reggio Emilia) ;
Slager, Susan L. (Mayo Clinic) ;
Hemminki, Kari (Charles University in Prague) ;
Li, Yang (Hannover Medical School) ;
Berndt, Sonja I. (National Institutes of Health (Estats Units d'Amèrica)) ;
Casabonne, Delphine (Universitat de Barcelona) ;
Alcoceba, Miguel (Instituto de Investigación Biomédica de Salamanca) ;
Puiggros, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Netea, Mihai G. (Department for Immunology & Metabolism. University of Bonn) ;
Försti, Asta (Hopp Children's Cancer Center) ;
Canzian, Federico (German Cancer Research Center) ;
Sainz, Juan (Department of Biochemistry and Molecular Biology. Universidad de Granada)
Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of GWAS-identified risk variants to predict disease progression and patient survival remains unexplored. [...]
2023 - 10.3390/ijms24098005
International journal of molecular sciences, Vol. 24 Núm. 9 (may 2023) , p. 8005
|
|
|
5.
|
|
10 p, 1.1 MB |
Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome
/
Prasad, Aparna (Hospital del Mar (Barcelona, Catalunya)) ;
Rabionet, Raquel (Hospital del Mar (Barcelona, Catalunya)) ;
Espinet, Blanca (Hospital del Mar (Barcelona, Catalunya)) ;
Zapata, Luis (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Puiggros, Anna (Hospital del Mar (Barcelona, Catalunya)) ;
Melero, Carme (Hospital del Mar (Barcelona, Catalunya)) ;
Puig, Anna (Hospital del Mar (Barcelona, Catalunya)) ;
Sarria-Trujillo, Yaris (Hospital del Mar (Barcelona, Catalunya)) ;
Ossowski, Stephan (Universitat Pompeu Fabra) ;
Garcia Muret, Maria Pilar (Institut d'Investigació Biomèdica Sant Pau) ;
Estrach, Teresa (Hospital Clínic i Provincial de Barcelona) ;
Servitje, Octavio (Hospital Universitari de Bellvitge) ;
Lopez-Lerma, Ingrid (Hospital Universitari Vall d'Hebron) ;
Gallardo, Fernando (Hospital del Mar (Barcelona, Catalunya)) ;
Pujol Vallverdú, Ramón M (Hospital del Mar (Barcelona, Catalunya)) ;
Estivill, Xavier (Hospital del Mar (Barcelona, Catalunya)) ;
Universitat Autònoma de Barcelona
Sézary syndrome is a leukemic form of cutaneous T-cell lymphoma with an aggressive clinical course. The genetic etiology of the disease is poorly understood, with chromosomal abnormalities and mutations in some genes being involved in the disease. [...]
2016 - 10.1016/j.jid.2016.03.024
The Journal of investigative dermatology, Vol. 136 Núm. 7 (january 2016) , p. 1490-1499
|
|
|
6.
|
|
18 p, 4.4 MB |
TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype
/
Ramos-Campoy, Silvia (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Puiggros, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Kamaso, Joanna (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Beà, Sílvia (Centro de Investigación Biomédica en Red de Cáncer) ;
Bougeon, Sandrine (Lausanne University Hospital) ;
Larráyoz, María José (Universidad Pública de Navarra) ;
Costa, Dolors (Centro de Investigación Biomédica en Red de Cáncer) ;
Parker, Helen (University of Southampton) ;
Rigolin, Gian Matteo (St. Anna University Hospital) ;
Blanco, María Laura (Institut d'Investigació Biomèdica Sant Pau) ;
Collado, Rosa (Consorcio Hospital General Universitario) ;
Ancín, Idoya (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Salgado, Rocío (Fundación Jiménez Díaz) ;
Moro-García, Marco A. (Hospital Universitario Central de Asturias) ;
Baumann, Tycho (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Gimeno, Eva (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Moreno, Carol (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Salido, Marta (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Calvo, Xavier (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Calasanz, M.J (Universidad Pública de Navarra) ;
Cuneo, Antonio (Hematology Section. St. Anna University Hospital) ;
Nguyen-Khac, Florence (Sorbonne University) ;
Oscier, David (Royal Bournemouth Hospital) ;
Haferlach, Claudia (MLL Munich Leukemia Laboratory) ;
Strefford, Jonathan C (University of Southampton) ;
Schoumans, Jacqueline (Lausanne University Hospital) ;
Espinet, Blanca (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Universitat Autònoma de Barcelona
Chromothripsis (cth) has been associated with a dismal outcome and poor prognosis factors in patients with chronic lymphocytic leukemia (CLL). Despite being correlated with high genome instability, previous studies have not assessed the role of cth in the context of genomic complexity. [...]
2022 - 10.3390/cancers14153715
Cancers, Vol. 14 Núm. 15 (august 2022) , p. 3715
|
|
|
7.
|
|
13 p, 1.1 MB |
ZooMS confirms geometric morphometrics species identification of ancient sheep and goat
/
Jeanjean, Marine (Université de Montpellier) ;
McGrath, Krista (Universitat Autònoma de Barcelona. Departament de Prehistòria) ;
Valenzuela-Lamas, Silvia (Institució Milà i Fontanals) ;
Nieto-Espinet, Ariadna (Universitat de Lleida. Departament de Prehistòria) ;
Schafberg, Renate (Martin Luther University Halle-Wittenberg) ;
Parés-Casanova, Pere M (Institució Catalana d'Història Natural) ;
Jiménez-Manchón, Sergio (Institució Milà i Fontanals de Recerca en Humanitats) ;
Guintard, Claude (École Nationale Vétérinaire, Agroalimentaire et de l'Alimentation, Nantes-Atlantique (Oniris)) ;
Tekkouk, Faiza (University of Frères Mentouri) ;
Ridouh, Rania (University of Frères Mentouri) ;
Mureau, Cyprien (Université de Montpellier) ;
Evin, Allowen (Université de Montpellier)
Geometric morphometrics can effectively distinguish isolated third lower molars of present-day sheep and goat, but its applicability to archaeological specimens has yet to be established. Using a modern reference collection of 743 sheep and goats and a two-dimensional landmark-based geometric morphometric (GMM) protocol, this study aimed to morphometrically identify 109 archaeological specimens, used as case studies, dating from the Late Neolithic to the modern period/era. [...]
2023 - 10.1098/rsos.230672
Royal Society Open Science, Vol. 10 Núm. 9 (2023) , article 230672
|
|
|
8.
|
|
12 p, 1.5 MB |
The valve uptake index : improving assessment of prosthetic valve endocarditis and updating [ 18 F]FDG PET/CT(A) imaging criteria
/
Roque, Albert (Hospital Universitari Vall d'Hebron) ;
Pizzi, María N (Hospital Universitari Vall d'Hebron) ;
Fernández-Hidalgo, Nuria (Hospital Universitari Vall d'Hebron) ;
Romero-Farina, Guillermo (Hospital Universitari Vall d'Hebron) ;
Burcet, Gemma (Hospital Universitari Vall d'Hebron) ;
Reyes-Juarez, José Luis (Hospital Universitari Vall d'Hebron) ;
Espinet, Carina (Hospital Universitari Vall d'Hebron) ;
Castell-Conesa, Joan (Hospital Universitari Vall d'Hebron) ;
Escobar, Manuel (Hospital Universitari Vall d'Hebron) ;
Ferreira-Gonzalez, Ignacio (Hospital Universitari Vall d'Hebron) ;
Aguadé-Bruix, Santiago (Hospital Universitari Vall d'Hebron) ;
Cuellar-Calabria, Hug (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Diagnosis of prosthetic valve endocarditis (PVE) by positron emission computed tomography angiography (PET/CTA) is based on visual and quantitative morpho-metabolic features. However, the fluorodeoxyglucose (FDG) uptake pattern can be sometimes visually unclear and susceptible to subjectivity. [...]
2022 - 10.1093/ehjci/jeab279
European Heart Journal Cardiovascular Imaging, Vol. 23 (january 2022) , p. 1260-1271
|
|
|
9.
|
|
1 p, 825.9 KB |
Correction : Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
/
Mansouri, Larry (Karolinska Institutet (Estocolm, Suècia)) ;
Thorvaldsdottir, Birna (Karolinska Institutet (Estocolm, Suècia). Department of Molecular Medicine and Surgery) ;
Sutton, Lesley-Ann (Karolinska Institutet (Estocolm, Suècia)) ;
Karakatsoulis, Georgios (University of Ioannina) ;
Meggendorfer, Manja (MLL Munich Leukemia Laboratory) ;
Parker, Helen (University of Southampton) ;
Nadeu, Ferran (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Brieghel, Christian (Copenhagen University Hospital) ;
Laidou, Stamatia (Institute of Applied Biosciences) ;
Moia, Riccardo (Università del Piemonte Orientale) ;
Rossi, Davide (Institute of Oncology Research) ;
Catherwood, Mark (Queen's University Belfast) ;
Kotaskova, Jana (Masaryk University) ;
Delgado, Julio (Hospital Clínic i Provincial de Barcelona) ;
Rodríguez-Vicente, Ana E. (Universidad de Salamanca) ;
Benito, Rocío (Universidad de Salamanca) ;
Rigolin, Gian Matteo (University of Ferrara) ;
Bonfiglio, Silvia (Università Vita Salute San Raffaele) ;
Scarfo, Lydia (Università Vita Salute San Raffaele) ;
Mattsson, Mattias (Uppsala University) ;
Davis, Zadie (University Hospitals Dorset) ;
Gogia, Ajay (All India Institute of Medical Sciences (Nova Delhi, Índia)) ;
Rani, Lata (All India Institute of Medical Sciences (Nova Delhi, Índia)) ;
Baliakas, Panagiotis (Uppsala University) ;
Foroughi-Asl, Hassan (Karolinska Institutet (Estocolm, Suècia)) ;
Jylhä, Cecilia (Karolinska Institutet (Estocolm, Suècia)) ;
Skaftason, Aron (Karolinska Institutet (Estocolm, Suècia)) ;
Rapado, Inmaculada (Centro Nacional de Investigaciones Oncológicas Carlos III (Espanya)) ;
Miras, Fatima (Hospital Universitario 12 de Octubre (Madrid)) ;
Martinez-Lopez, Joaquín (Centro Nacional de Investigaciones Oncológicas Carlos III (Espanya)) ;
de la Serna, Javier (Centro Nacional de Investigaciones Oncológicas Carlos III (Espanya)) ;
Rivas, Jesús María Hernández (Universidad de Salamanca) ;
Thornton, Patrick (Beaumont Hospital (Dublín, Irlanda)) ;
Larráyoz, María José (Universidad de Navarra) ;
Calasanz, M.J (Universidad de Navarra) ;
Fésüs, Viktória (Semmelweis University) ;
Mátrai, Zoltán (Central Hospital of Southern Pest-National Institute of Hematology and Infectious Diseases (Budapest, Hongria)) ;
Bödör, Csaba (Semmelweis University) ;
Smedby, Karin E. (Karolinska Institutet (Estocolm, Suècia)) ;
Espinet, Blanca (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Puiggros, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Gupta, Ritu (All India Institute of Medical Sciences (Nova Delhi, Índia)) ;
Bullinger, Lars (Charité - Universitätsmedizin Berlin) ;
Bosch José, Francesc Xavier 1947- (Vall d'Hebron Institut d'Oncologia) ;
Tazón-Vega, Bárbara (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Baran-Marszak, Fanny (Hôpital Avicenne AP-HP) ;
Oscier, David (University Hospitals Dorset) ;
Nguyen-Khac, Florence (Sorbonne University) ;
Zenz, Thorsten (University Hospital of Zurich) ;
Terol, Maria Jose (Universitat de València) ;
Cuneo, Antonio (University of Ferrara) ;
Hernández-Sánchez, María (Universidad de Salamanca) ;
Pospisilova, Sarka (Masaryk University) ;
Mills, Ken (Queen's University Belfast) ;
Gaidano, Gianluca (Università del Piemonte Orientale) ;
Niemann, Carsten U. (Copenhagen University Hospital) ;
Campo, Elias (Hospital Clínic i Provincial de Barcelona) ;
Strefford, Jonathan C. (University of Southampton) ;
Ghia, Paolo (Università Vita Salute San Raffaele) ;
Stamatopoulos, Kostas (Institute of Applied Biosciences) ;
Rosenquist, Richard (Karolinska University Hospital and Karolinska Institutet (Suècia))
2023 - 10.1038/s41375-023-01813-3
Leukemia, Vol. 37 (january 2023) , p. 504
|
|
|
10.
|
|
9 p, 1.7 MB |
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status : a study by ERIC in HARMONY
/
Mansouri, Larry (Karolinska Institutet (Estocolm, Suècia)) ;
Thorvaldsdottir, Birna (Karolinska Institutet (Estocolm, Suècia)) ;
Sutton, Lesley-Ann (Karolinska Institutet (Estocolm, Suècia)) ;
Karakatsoulis, Georgios (University of Ioannina. Department of Mathematics) ;
Meggendorfer, Manja (MLL Munich Leukemia Laboratory) ;
Parker, Helen (University of Southampton) ;
Nadeu, Ferran (Centro de Investigación Biomédica en Red de Cáncer) ;
Brieghel, Christian (Copenhagen University Hospital. Department of Hematology, Rigshospitalet) ;
Laidou, Stamatia (Centre for Research and Technology Hellas (Tessalònica, Grècia)) ;
Moia, Riccardo (Università del Piemonte Orientale) ;
Rossi, Davide (Institute of Oncology Research (Suïssa)) ;
Catherwood, Mark (Queen's University Belfast) ;
Kotaskova, Jana (Masaryk University) ;
Delgado, Julio (Universitat de Barcelona) ;
Rodríguez-Vicente, Ana E. (Hospital Universitario de Salamanca) ;
Benito, Rocío (Hospital Universitario de Salamanca) ;
Rigolin, Gian Matteo (University of Ferrara) ;
Bonfiglio, Silvia (Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele) ;
Scarfo, Lydia (Università Vita Salute San Raffaele) ;
Mattsson, Mattias (Uppsala University. Department of Immunology, Genetics and Pathology) ;
Davis, Zadie (Molecular Pathology Department, University Hospitals Dorset) ;
Gogia, Ajay (All India Institute of Medical Sciences (Nova Delhi, Índia)) ;
Rani, Lata (All India Institute of Medical Sciences (Nova Delhi, Índia)) ;
Baliakas, Panagiotis (Uppsala University. Department of Immunology, Genetics and Pathology) ;
Foroughi-Asl, Hassan (Karolinska Institutet (Estocolm, Suècia)) ;
Jylhä, Cecilia (Karolinska Institutet (Estocolm, Suècia)) ;
Skaftason, Aron (Karolinska Institutet (Estocolm, Suècia)) ;
Rapado, Inmaculada (Spanish National Cancer Research) ;
Miras, Fatima (Hospital Universitario 12 de Octubre (Madrid)) ;
Martinez-Lopez, Joaquín (Spanish National Cancer Research) ;
de la Serna, Javier (Spanish National Cancer Research) ;
Rivas, Jesús María Hernández (Hospital Universitario de Salamanca) ;
Thornton, Patrick (Beaumont Hospital. Haematology Department) ;
Larráyoz, María José (Instituto de Investigación Sanitaria de Navarra) ;
Calasanz, M.J (Instituto de Investigación Sanitaria de Navarra) ;
Fésüs, Viktória (Semmelweis University) ;
Mátrai, Zoltán (Central Hospital of Southern Pest-National Institute of Hematology and Infectious Diseases, Budapest, Hungary) ;
Bödör, Csaba (Semmelweis University) ;
Smedby, Karin E. (Karolinska Institutet (Suècia). Department of Medicine Solna) ;
Espinet, Blanca (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Puiggros, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Gupta, Ritu (All India Institute of Medical Sciences (Nova Delhi, Índia)) ;
Bullinger, Lars (Charité - Universitätsmedizin Berlin) ;
Bosch José, Francesc Xavier 1947- (Vall d'Hebron Institut d'Oncologia) ;
Tazón-Vega, Bárbara (Vall d'Hebron Institut d'Oncologia) ;
Baran-Marszak, Fanny (Service d'hématologie Biologique Hôpital Avicenne Assistance Publique des Hôpitaux de Paris) ;
Oscier, David (University Hospitals Dorset) ;
Nguyen-Khac, Florence (Sorbonne University) ;
Zenz, Thorsten (University Hospital and University of Zurich. Department of Oncology and Haematology) ;
Terol, Maria Jose (University of Valencia. Department of Hematology) ;
Cuneo, Antonio (University of Ferrara. Hematology-Department of Medical Sciences) ;
Hernández-Sánchez, María (Hospital Universitario de Salamanca) ;
Pospisilova, Sarka (Masaryk University. Central European Institute of Technology) ;
Mills, Ken (Queen's University Belfast) ;
Gaidano, Gianluca (Università del Piemonte Orientale) ;
Niemann, Carsten U. (Copenhagen University Hospital) ;
Campo, Elias (Universitat de Barcelona) ;
Strefford, Jonathan C. (University of Southampton) ;
Ghia, Paolo (Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele) ;
Stamatopoulos, Kostas (Institute of Applied Biosciences (Grècia)) ;
Rosenquist, Richard (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Universitat Autònoma de Barcelona
Recent evidence suggests that the prognostic impact of gene mutations in patients with chronic lymphocytic leukemia (CLL) may differ depending on the immunoglobulin heavy variable (IGHV) gene somatic hypermutation (SHM) status. [...]
2022 - 10.1038/s41375-022-01802-y
Leukemia, Vol. 37 (december 2022) , p. 339-347
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
